MetaADEDB 2.0 @ LMMD
Protoveratrines
(SFCJOAFKJHVNCF-UHFFFAOYSA-N)
Structure
SMILES
CCC(C(=O)OC1C(O)C2C(C3C1(O)C1C(OC(=O)C)C(OC(=O)C)C4C5(C1(C3)OC4(O)C(CC5)OC(=O)C(CC)(O)C)C)CN1C(C2(C)O)CCC(C1)C)C.CCC(C(=O)OC1C(O)C2C(C3C1(O)C1C(OC(=O)C)C(OC(=O)C)C4C5(C1(C3)OC4(O)C(CC5)OC(=O)C(C(O)C)(O)C)C)CN1C(C2(C)O)CCC(C1)C)C
Molecular Formula:
C82H126N2O29
Molecular Weight:
1603.870
Log P:
2.0610
Hydrogen Bond Acceptor:
31
Hydrogen Bond Donor:
11
TPSA:
457.87
CAS Number(s):
8053-18-7
Synonym(s)
1.
Protoveratrines
2.
Cryptenamine
3.
Neoprotoveratrin
4.
Protoverin
5.
Veratetrin
6.
Protalba
7.
Protoveratrine A
8.
Tensatrin
9.
Veralba
External Link(s)
MeSHD011526
PubChem Compound408888
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Anorexia4942478CTD
2Fatigue4942478CTD
3Nausea4942478CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.